Yasser W Barsoum, MD
Nephrology · Visalia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 33 years
- Graduated 1993
Offices
1 location
Looking this up.
Hospitals listed: 052666 · 052696 · 053506 · 552740 · 552806 · Adventist Health Hanford · Adventist Health Reedley · Adventist Health Tulare · Kaweah Health Medical Center · Sierra View Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barsoum’s office at (559) 697-6290 to ask if they take your plan before you enroll.
California Medical Board record
Licence A91481 · Current
Licensed to practise in California · since 2005 · expires 2027-06-30 · Ain Shams University Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health HanfordHanford, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.277, Oct 2024 – Sep 2025
- Adventist Health ReedleyReedley, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 76% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Adventist Health TulareTulare, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Kaweah Health Medical CenterVisalia, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Kaweah Delta Health Care DistrictPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 239.86 (194.11 to 285.6) · 104 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025
- Sierra View Medical CenterPorterville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 52% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Hanford
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 614 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.38 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.5 (130.11 to 250.89) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 269 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 1,486 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,684 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,819 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.67 (0.36 to 4.98) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 154 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.65 (1.02 to 4.28) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.19) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 147 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 1) · 3,186 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.418 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 38 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 328 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 14.5 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22 · 380 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 407 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10 to 17) · 896 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 228 cases | No different | Jan 2024 – Dec 2024 |
What patients said (947 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Adventist Health Reedley
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 41 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 101 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 169 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.93) · 142 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.929 | No different | Oct 2024 – Sep 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -28.8 · 37 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 39 cases | None | Jul 2023 – Jun 2025 |
What patients said (133 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Adventist Health Tulare
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.13) · 41 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.48 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.9 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 49 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 441 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 835 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 870 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.83 (1.25 to 6.42) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.25 (0.54 to 3.95) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.44 (0 to 1.57) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.436 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 94 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.4 · 67 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.4 · 129 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 141 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 46 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 100 cases | No different | Jan 2024 – Dec 2024 |
What patients said (219 patients answered, 14% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 1 |
| Discharge information | 5 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for Kaweah Health Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 3 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 239.86 (194.11 to 285.6) · 104 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.22 (0.28 to 2.16) · 1,600 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.53 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 145 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.8 · 626 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.1 · 741 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 373 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,927 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,045 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.38) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.81 to 5.63) · 2,251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.53 to 3.61) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.45 to 3.13) · 2,231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.88 (1.1 to 12.66) · 799 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.59 (0 to 7.19) · 759 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 0.89) · 8,159 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 43 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.728 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.405 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.023 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.551 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 344 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 799 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 31.4 · 686 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6 · 734 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 776 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.6 to 7.6) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.9 (6.6 to 11.9) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 317 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.3 to 14) · 1,748 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 680 cases | No different | Jan 2024 – Dec 2024 |
What patients said (435 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sierra View Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 10 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 548 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.64 to 1.51) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.5 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 58 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 21.4 · 330 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.8 · 112 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 938 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.37 (0.15 to 0.6) · 2,512 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,538 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.04 (1.54 to 6.53) · 287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.93) · 280 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.81 (1.82 to 21.81) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.99 (2.68 to 11.29) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.05 (0.54 to 3.56) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,881 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 27 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.606 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 57 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 170 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.8 · 55 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -37.5 · 145 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 362 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (3.8 to 8.7) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.9 to 14) · 84 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10 to 17.3) · 788 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 188 cases | No different | Jan 2024 – Dec 2024 |
What patients said (325 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 52% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$666,937
Medicare paid this office $666,937 for 500 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 460 | $291,892 | $109 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $104,210 | $298 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $80,081 | $99 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $50,384 | $246 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $33,675 | $143 |
See all 16 services
| Return visit (30+ min) | 460 | $291,892 | $109 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 43 | $104,210 | $298 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $80,081 | $99 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $50,384 | $246 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $33,675 | $143 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 451 | $27,844 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $13,516 | $66 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 109 | $11,929 | $34 |
| New patient visit (45+ min) | 82 | $11,578 | $141 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 116 | $11,335 | $43 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 61 | $10,327 | $42 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 58 | $6,297 | $55 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 85 | $5,725 | $44 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $2,882 | $21 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 83 | $1,513 | $18 |
| Injection of drug or substance under skin or into muscle | 17 | $965 | $13 |
Who their Medicare patients are
500 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 18% · Women 53% · Also on Medicaid 40% · Health risk score 2.83. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 67% · Coronary heart disease 45% · Heart failure 39% · Depression 29% · Atrial fibrillation 24% · COPD 20% · Cancer 14% · Dementia 13% · Stroke 10%.
The office billed $1,293,267, Medicare allowed $838,933 and paid $666,937; for 8,006 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 500 | 8,006 | 74 | 2.83 | $1,293,267 | $666,937 |
| 2023 | 497 | 5,089 | 74 | 2.96 | $1,166,038 | $569,736 |
| 2022 | 502 | 5,578 | 74 | 2.94 | $1,303,556 | $649,184 |
| 2021 | 538 | 5,563 | 74 | 3.04 | $1,338,962 | $664,255 |
| 2020 | 527 | 5,362 | 73 | 3.44 | $1,339,932 | $583,012 |
| 2019 | 527 | 5,709 | 73 | 3.53 | $1,289,100 | $578,303 |
| 2018 | 458 | 4,419 | 72 | 3.64 | $950,640 | $419,455 |
| 2017 | 446 | 4,002 | 72 | 3.55 | $826,006 | $398,954 |
| 2016 | 516 | 3,985 | 72 | 3.48 | $797,995 | $364,317 |
| 2015 | 490 | 3,610 | 71 | 3.46 | $795,380 | $361,350 |
| 2014 | 469 | 3,196 | 72 | 3.25 | $722,361 | $292,173 |
| 2013 | 655 | 3,047 | 71 | 4.37 | $647,835 | $236,647 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 452 | $292,939 | $99 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $100,211 | $288 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $57,001 | $97 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $46,654 | $238 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $32,771 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $13,613 | $140 |
| New patient visit (45+ min) | 98 | $12,795 | $131 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $4,126 | $101 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $2,360 | $20 |
| Injection of drug or substance under skin or into muscle | 12 | $831 | $10 |
2022: 11 services
| Return visit (30+ min) | 457 | $320,724 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $114,380 | $84 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 44 | $108,960 | $297 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $51,776 | $247 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 103 | $20,024 | $109 |
| New patient visit (45+ min) | 98 | $13,538 | $138 |
| Transitional care management services for problem of at least moderate complexity | 19 | $3,276 | $172 |
| Injection of drug or substance under skin or into muscle | 17 | $2,076 | $12 |
| Emergency department visit with moderate level of medical decision making | 15 | $1,874 | $99 |
| Hemodialysis procedure with physician evaluation | 15 | $1,258 | $60 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 11 | $519 | $29 |
2021: 9 services
| Return visit (30+ min) | 472 | $293,572 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 161 | $132,861 | $85 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 50 | $129,049 | $301 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $52,712 | $246 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 163 | $28,147 | $107 |
| New patient visit (45+ min) | 92 | $12,692 | $138 |
| Emergency department visit with moderate level of medical decision making | 21 | $2,688 | $96 |
| Hemodialysis procedure with physician evaluation | 28 | $1,820 | $61 |
| Injection of drug or substance under skin or into muscle | 15 | $1,062 | $12 |
2020: 9 services
| Return visit (30+ min) | 444 | $202,076 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 167 | $149,916 | $87 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 56 | $110,012 | $237 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $54,918 | $200 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 167 | $32,765 | $111 |
| New patient visit (45+ min) | 84 | $10,436 | $124 |
| Hemodialysis procedure with physician evaluation | 36 | $3,269 | $61 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $2,986 | $157 |
| Emergency department visit with moderate level of medical decision making | 12 | $1,375 | $98 |
2019: 8 services
| Return visit (30+ min) | 455 | $205,686 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 179 | $149,981 | $85 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 64 | $101,752 | $198 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $56,993 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 182 | $35,662 | $108 |
| New patient visit (45+ min) | 90 | $10,940 | $122 |
| Hemodialysis procedure with physician evaluation | 23 | $3,616 | $60 |
| Injection of drug or substance under skin or into muscle | 11 | $747 | $14 |
2018: 9 services
| Return visit (30+ min) | 417 | $177,922 | $83 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 55 | $71,959 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $56,580 | $73 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 45 | $54,820 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 121 | $24,331 | $107 |
| New patient visit (45+ min) | 90 | $11,042 | $123 |
| Hemodialysis procedure with physician evaluation | 32 | $6,809 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,688 | $40 |
| Injection of drug or substance under skin or into muscle | 12 | $979 | $16 |
2017: 12 services
| Return visit (30+ min) | 359 | $126,125 | $85 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 68 | $80,017 | $228 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $68,336 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $47,928 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 101 | $18,912 | $106 |
| Hemodialysis procedure with physician evaluation | 48 | $17,947 | $58 |
| Short return visit (20+ min) | 102 | $12,030 | $57 |
| New patient visit (45+ min) | 44 | $5,189 | $118 |
| New patient visit (30+ min) | 50 | $4,098 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,643 | $68 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,141 | $88 |
| Injection of drug or substance under skin or into muscle | 11 | $944 | $21 |
2016: 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 74 | $86,617 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 173 | $55,012 | $58 |
| Return visit (30+ min) | 278 | $52,968 | $81 |
| Short return visit (20+ min) | 245 | $34,451 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $28,564 | $84 |
| Hemodialysis procedure with physician evaluation | 69 | $24,789 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $18,952 | $159 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $18,440 | $228 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 106 | $15,727 | $109 |
| Home dialysis services per month (20 years or older) | 12 | $13,889 | $180 |
| New patient visit (45+ min) | 74 | $8,961 | $121 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,328 | $83 |
| New patient visit (30+ min) | 12 | $1,061 | $88 |
2015: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 235 | $96,959 | $85 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $81,230 | $190 |
| Return visit (30+ min) | 293 | $73,427 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 205 | $44,837 | $161 |
| Hemodialysis procedure with physician evaluation | 78 | $20,648 | $59 |
| Short return visit (20+ min) | 124 | $14,515 | $59 |
| New patient visit (45+ min) | 71 | $8,969 | $126 |
| Hospital discharge day management, more than 30 minutes | 29 | $3,071 | $88 |
| Dialysis procedure including 1 evaluation | 11 | $2,735 | $70 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $1,810 | $151 |
2014: 11 services
| Return visit (30+ min) | 234 | $60,452 | $85 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $49,821 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 184 | $44,422 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $44,189 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 184 | $22,589 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $18,237 | $160 |
| Hemodialysis procedure with physician evaluation | 73 | $17,569 | $59 |
| Hospital discharge day management, more than 30 minutes | 122 | $11,104 | $87 |
| New patient visit (45+ min) | 48 | $6,305 | $131 |
| Long return visit (40+ min) | 31 | $4,260 | $115 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $2,862 | $151 |
2013: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 296 | $54,755 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 224 | $28,905 | $107 |
| Hemodialysis procedure with physician evaluation | 134 | $28,845 | $57 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 61 | $25,272 | $226 |
| Return visit (30+ min) | 164 | $24,897 | $84 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 69 | $21,824 | $187 |
| Long return visit (40+ min) | 95 | $11,923 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 102 | $7,880 | $31 |
| Short return visit (20+ min) | 95 | $6,950 | $56 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $5,946 | $149 |
| New patient visit (45+ min) | 43 | $5,292 | $123 |
| Dialysis procedure including 1 evaluation | 14 | $4,047 | $69 |
| New patient visit (60+ min) | 19 | $2,916 | $153 |
Medicaid work
$63,484 in 2024
Medicaid paid $63,484 for 1,957 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 270 | $30,348 |
| Return visit (30+ min) | 969 | $26,366 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 119 | $3,059 |
| 1ST HOSP IP/OBS HIGH 75 | 108 | $2,169 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 123 | $1,239 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 329 | $283 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 12 | $20 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 13 | $0 |
| Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 14 | $0 |
| 2024 | 1,957 | 9 | 99 | $63,484 |
| 2023 | 2,778 | 10 | 103 | $65,006 |
| 2022 | 1,748 | 5 | 89 | $46,298 |
| 2021 | 2,239 | 13 | 87 | $34,855 |
| 2020 | 3,438 | 18 | 80 | $49,238 |
| 2019 | 2,242 | 5 | 103 | $50,258 |
| 2018 | 1,731 | 5 | 81 | $25,582 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 313 | $33,710 |
| Return visit (30+ min) | 1,525 | $22,137 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 95 | $2,850 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 263 | $2,234 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 158 | $2,084 |
| 1ST HOSP IP/OBS HIGH 75 | 82 | $1,991 |
| HEMOGLOBIN A1C LEVEL >9.0% | 123 | $0 |
| Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 189 | $0 |
| Bp scrn perf rec interval | 17 | $0 |
| Pre-htn or htn doc, f/u indc | 13 | $0 |
2022
| Return visit (30+ min) | 1,232 | $21,962 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 200 | $16,132 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 41 | $3,123 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 38 | $2,912 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 237 | $2,168 |
2021
| Return visit (30+ min) | 919 | $15,976 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 145 | $12,602 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 30 | $3,320 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 243 | $2,094 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 561 | $825 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 37 | $38 |
| Pneumococcal vaccine administered or previously received (COPD) (PV) (IBD) | 27 | $0 |
| Bmi is documented above normal parameters and a follow-up plan is documented | 50 | $0 |
| Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 17 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 27 | $0 |
| Most recent systolic blood pressure >= 140 mmhg | 16 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 67 | $0 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 315 | $16,676 |
| Return visit (30+ min) | 906 | $11,575 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 130 | $8,192 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 304 | $7,653 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 52 | $2,300 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 504 | $863 |
| Patient screened for tobacco use and identified as a tobacco non-user | 328 | $713 |
| Bmi is documented above normal parameters and a follow-up plan is documented | 210 | $375 |
| Most recent diastolic blood pressure < 90 mmhg | 197 | $300 |
| Most recent systolic blood pressure < 140 mmhg | 120 | $188 |
| Flu immunize order/admin | 56 | $113 |
| Bp scrn perf rec interval | 14 | $106 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 490 | $18,737 |
| Return visit (30+ min) | 1,031 | $12,792 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 199 | $10,046 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 434 | $5,271 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 88 | $3,411 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 353 | $9,243 |
| Return visit (30+ min) | 903 | $6,210 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 262 | $5,936 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 185 | $2,432 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 28 | $1,760 |
Drugs they prescribed that Part D paid
$1,313,765
Pharmacies billed $1,313,765 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (94 of 6,377) in 2024. A higher opioid share than 9 in 10 peers; the typical nephrology clinician is at 0%.
5,072 generic and 1,244 brand-name prescriptions · $1,313,765 in drug cost · 232 antibiotic prescriptions to 129 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 134 | $138,530 | $1,034 |
| Sevelamer | 34 | $116,051 | $3,413 |
| Velphoro | 29 | $97,118 | $3,349 |
| Lokelma | 71 | $70,641 | $995 |
| Xphozah | 19 | $53,326 | $2,807 |
See all 98 drugs
| Ozempic | 134 | $138,530 | $1,034 |
| Sevelamer | 34 | $116,051 | $3,413 |
| Velphoro | 29 | $97,118 | $3,349 |
| Lokelma | 71 | $70,641 | $995 |
| Xphozah | 19 | $53,326 | $2,807 |
| Clinolipid | 133 | $47,339 | $356 |
| Lactulose | 39 | $46,541 | $1,193 |
| Retacrit | 64 | $46,298 | $723 |
| Januvia | 41 | $45,970 | $1,121 |
| Eliquis | 35 | $40,956 | $1,170 |
| Sevelamer Carbonate | 122 | $38,055 | $312 |
| Mounjaro | 33 | $36,838 | $1,116 |
| Procrit | 23 | $36,029 | $1,566 |
| Repatha Sureclick | 54 | $34,638 | $641 |
| Rybelsus | 21 | $30,261 | $1,441 |
| Prosol | 172 | $27,733 | $161 |
| Glyxambi | 22 | $25,172 | $1,144 |
| Cinacalcet | 137 | $23,180 | $169 |
| Jardiance | 13 | $18,086 | $1,391 |
| Repatha | 30 | $17,197 | $573 |
| Tradjenta | 19 | $16,398 | $863 |
| Megestrol Acetate | 54 | $11,596 | $215 |
| Midodrine | 63 | $7,717 | $122 |
| Basaglar Kwikpen U-100 | 21 | $7,487 | $357 |
| Bumetanide | 177 | $7,256 | $41 |
| Omega-3 Acid Ethyl Esters | 98 | $5,389 | $55 |
| Clinisol | 26 | $4,662 | $179 |
| Minoxidil | 78 | $4,447 | $57 |
| Calcium Acetate | 34 | $4,391 | $129 |
| Comfort Ez Pen Needle | 27 | $4,174 | $155 |
| Atorvastatin | 417 | $3,542 | $8 |
| Albuterol Sulfate Hfa | 99 | $3,228 | $33 |
| Calcitriol | 140 | $3,099 | $22 |
| Lantus Solostar | 19 | $3,016 | $159 |
| Potassium Citrate Er | 28 | $2,906 | $104 |
| Levothyroxine | 224 | $2,760 | $12 |
| Lisinopril | 253 | $2,510 | $10 |
| Hydralazine | 132 | $2,131 | $16 |
| Valsartan | 43 | $2,120 | $49 |
| Febuxostat | 15 | $1,797 | $120 |
| Nifedipine Er | 39 | $1,661 | $43 |
| Sucralfate | 12 | $1,584 | $132 |
| Tamsulosin | 102 | $1,577 | $15 |
| Metoprolol | 68 | $1,412 | $21 |
| Carvedilol | 119 | $1,160 | $10 |
| Losartan | 124 | $1,127 | $9 |
| Gemfibrozil | 50 | $1,106 | $22 |
| Oxybutynin Chloride | 14 | $1,074 | $77 |
| Pantoprazole | 103 | $1,018 | $10 |
| Potassium Chloride | 46 | $1,008 | $22 |
| Amlodipine Besylate | 168 | $1,000 | $6 |
| Allopurinol | 82 | $943 | $11 |
| Fenofibrate | 26 | $900 | $35 |
| Vitamin D2 | 52 | $892 | $17 |
| Alprazolam | 220 | $857 | $4 |
| Metoprolol | 119 | $844 | $7 |
| Paricalcitol | 11 | $790 | $72 |
| Ventolin Hfa | 15 | $789 | $53 |
| Fenofibrate | 16 | $728 | $45 |
| Fludrocortisone Acetate | 13 | $666 | $51 |
| Gabapentin | 46 | $650 | $14 |
| Celecoxib | 17 | $635 | $37 |
| Doxazosin Mesylate | 49 | $620 | $13 |
| Ciprofloxacin | 100 | $597 | $6 |
| Azithromycin | 48 | $593 | $12 |
| Fluticasone Propionate | 63 | $584 | $9 |
| Metolazone | 31 | $515 | $17 |
| Chlorthalidone | 31 | $382 | $12 |
| Olmesartan Medoxomil | 25 | $371 | $15 |
| Clonidine | 47 | $366 | $8 |
| Zolpidem | 113 | $358 | $3 |
| Ondansetron Odt | 25 | $355 | $14 |
| Omeprazole | 33 | $350 | $11 |
| Ondansetron | 27 | $313 | $12 |
| Rosuvastatin | 18 | $298 | $17 |
| Meclizine | 15 | $266 | $18 |
| Ezetimibe | 11 | $242 | $22 |
| Prednisone | 70 | $230 | $3 |
| Furosemide | 31 | $221 | $7 |
| Hydrocodone-Acetaminophen | 33 | $218 | $7 |
| Loperamide | 19 | $212 | $11 |
| Ropinirole | 16 | $196 | $12 |
| Eszopiclone | 13 | $173 | $13 |
| Hydrocortisone | 23 | $161 | $7 |
| Spironolactone | 27 | $160 | $6 |
| Clopidogrel | 25 | $159 | $6 |
| Benazepril | 18 | $155 | $9 |
| Amoxicillin-Clavulanate Potass | 19 | $150 | $8 |
| Hydrochlorothiazide | 43 | $126 | $3 |
| Cephalexin | 19 | $126 | $7 |
| Sertraline | 27 | $115 | $4 |
| Irbesartan | 12 | $113 | $9 |
| Fluconazole | 16 | $103 | $6 |
| Metformin | 17 | $101 | $6 |
| Metronidazole | 17 | $99 | $6 |
| Warfarin | 20 | $95 | $5 |
| Hydromorphone | 11 | $87 | $8 |
| Tramadol | 50 | $75 | $1 |
Year by year
| 2024 | 6,377 | 540 | 2% (94) | 20% | $1,313,765 |
| 2023 | 6,410 | 527 | 2% (123) | 19% | $2,159,959 |
| 2022 | 6,099 | 476 | 3% (152) | 23% | $1,786,964 |
| 2021 | 5,710 | 449 | 2% (124) | 26% | $1,292,410 |
| 2020 | 5,989 | 401 | 3% (162) | 27% | $1,213,506 |
| 2019 | 5,106 | 372 | 3% (130) | 30% | $891,579 |
| 2018 | 4,580 | 352 | 3% (115) | 32% | $844,737 |
| 2017 | 5,034 | 314 | 2% (103) | 34% | $1,218,602 |
| 2016 | 4,476 | 273 | 3% (138) | 30% | $838,111 |
| 2015 | 3,526 | 238 | 2% (80) | 31% | $507,393 |
| 2014 | 2,639 | 222 | 3% (68) | 28% | $285,443 |
| 2013 | 1,733 | 272 | 2% (37) | 33% | $206,751 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 104 drugs
| Velphoro | 58 | $302,468 | $5,215 |
| Lactulose | 54 | $215,211 | $3,985 |
| Sevelamer Carbonate | 139 | $151,557 | $1,090 |
| Lokelma | 89 | $132,314 | $1,487 |
| Ozempic | 81 | $116,675 | $1,440 |
| Cinacalcet | 146 | $75,258 | $515 |
| Januvia | 44 | $70,409 | $1,600 |
| Procrit | 21 | $64,320 | $3,063 |
| Xifaxan | 15 | $51,599 | $3,440 |
| Clinolipid | 141 | $49,168 | $349 |
| Retacrit | 61 | $48,211 | $790 |
| Glyxambi | 26 | $44,135 | $1,697 |
| Rybelsus | 16 | $39,086 | $2,443 |
| Repatha Sureclick | 21 | $34,942 | $1,664 |
| Metformin Er Gastric | 12 | $34,124 | $2,844 |
| Tradjenta | 21 | $32,398 | $1,543 |
| Eliquis | 22 | $30,276 | $1,376 |
| Veltassa | 14 | $28,488 | $2,035 |
| Repatha | 33 | $24,994 | $757 |
| Midodrine | 67 | $24,890 | $371 |
| Novolog Flexpen | 20 | $20,058 | $1,003 |
| Calcium Acetate | 55 | $19,939 | $363 |
| Prosol | 128 | $18,930 | $148 |
| Febuxostat | 27 | $16,262 | $602 |
| Tacrolimus | 17 | $14,953 | $880 |
| Edarbi | 17 | $14,053 | $827 |
| Sucralfate | 29 | $13,899 | $479 |
| Megestrol Acetate | 38 | $10,977 | $289 |
| Bumetanide | 192 | $10,844 | $56 |
| Basaglar Kwikpen U-100 | 25 | $10,235 | $409 |
| Lantus Solostar | 14 | $9,722 | $694 |
| Atorvastatin | 406 | $8,498 | $21 |
| Minoxidil | 93 | $7,220 | $78 |
| Comfort Ez Pen Needle | 29 | $7,060 | $243 |
| Potassium Citrate Er | 35 | $6,311 | $180 |
| Nifedipine Er | 55 | $5,345 | $97 |
| Lisinopril | 256 | $5,098 | $20 |
| Clinisol | 26 | $5,014 | $193 |
| Levothyroxine | 237 | $4,679 | $20 |
| Valsartan | 32 | $4,243 | $133 |
| Dronabinol | 12 | $4,067 | $339 |
| Hydralazine | 144 | $4,027 | $28 |
| Losartan | 99 | $2,969 | $30 |
| Albuterol Sulfate Hfa | 96 | $2,912 | $30 |
| Tamsulosin | 109 | $2,904 | $27 |
| Pantoprazole | 129 | $2,855 | $22 |
| Celecoxib | 33 | $2,694 | $82 |
| Metoprolol | 155 | $2,682 | $17 |
| Ropinirole | 23 | $2,485 | $108 |
| Amlodipine Besylate | 118 | $2,421 | $21 |
| Gemfibrozil | 56 | $2,359 | $42 |
| Potassium Chloride | 49 | $2,074 | $42 |
| Carvedilol | 111 | $2,031 | $18 |
| Allopurinol | 89 | $1,928 | $22 |
| Fluticasone Propionate | 135 | $1,861 | $14 |
| Fludrocortisone Acetate | 21 | $1,775 | $85 |
| Gabapentin | 44 | $1,731 | $39 |
| Alprazolam | 267 | $1,613 | $6 |
| Gentamicin Sulfate | 13 | $1,510 | $116 |
| Calcitriol | 52 | $1,319 | $25 |
| Ventolin Hfa | 20 | $1,301 | $65 |
| Doxazosin Mesylate | 34 | $1,265 | $37 |
| Oxybutynin Chloride Er | 12 | $1,256 | $105 |
| Metoprolol | 50 | $1,128 | $23 |
| Fenofibrate | 18 | $988 | $55 |
| Chlorthalidone | 33 | $950 | $29 |
| Ezetimibe | 11 | $873 | $79 |
| Azithromycin | 61 | $852 | $14 |
| Clonidine | 41 | $836 | $20 |
| Hydrocodone-Acetaminophen | 61 | $781 | $13 |
| Sertraline | 52 | $770 | $15 |
| Clopidogrel | 32 | $764 | $24 |
| Zolpidem | 100 | $757 | $8 |
| Ondansetron | 32 | $750 | $23 |
| Constulose | 23 | $715 | $31 |
| Olmesartan Medoxomil | 19 | $662 | $35 |
| Metolazone | 34 | $633 | $19 |
| Furosemide | 46 | $629 | $14 |
| Finasteride | 16 | $624 | $39 |
| Ciprofloxacin | 69 | $606 | $9 |
| Ondansetron Odt | 36 | $590 | $16 |
| Rosuvastatin | 25 | $573 | $23 |
| Isosorbide Mononitrate Er | 12 | $550 | $46 |
| Loperamide | 28 | $520 | $19 |
| Omeprazole | 31 | $470 | $15 |
| Meclizine | 11 | $464 | $42 |
| Warfarin | 30 | $455 | $15 |
| Cephalexin | 21 | $422 | $20 |
| Prednisone | 65 | $379 | $6 |
| Benazepril | 22 | $368 | $17 |
| Hydrocortisone | 12 | $361 | $30 |
| Vitamin D2 | 42 | $360 | $9 |
| Spironolactone | 35 | $359 | $10 |
| Rizatriptan | 12 | $329 | $27 |
| Metformin | 24 | $329 | $14 |
| Montelukast | 11 | $284 | $26 |
| Losartan-Hydrochlorothiazide | 11 | $218 | $20 |
| Hydrochlorothiazide | 21 | $217 | $10 |
| Simvastatin | 14 | $196 | $14 |
| Hydromorphone | 24 | $192 | $8 |
| Amoxicillin-Clavulanate Potass | 15 | $175 | $12 |
| Eszopiclone | 18 | $157 | $9 |
| Metronidazole | 15 | $131 | $9 |
| Tramadol | 31 | $85 | $3 |
2022: 105 drugs
| Velphoro | 62 | $313,853 | $5,062 |
| Sevelamer Carbonate | 132 | $195,088 | $1,478 |
| Procrit | 42 | $105,767 | $2,518 |
| Ozempic | 55 | $86,477 | $1,572 |
| Lactulose | 50 | $71,849 | $1,437 |
| Januvia | 48 | $68,413 | $1,425 |
| Prosol | 353 | $65,050 | $184 |
| Cinacalcet | 132 | $64,734 | $490 |
| Lokelma | 58 | $59,333 | $1,023 |
| Clinolipid | 188 | $59,299 | $315 |
| Xifaxan | 13 | $48,125 | $3,702 |
| Rybelsus | 19 | $43,215 | $2,274 |
| Glyxambi | 24 | $37,523 | $1,563 |
| Veltassa | 25 | $30,120 | $1,205 |
| Tradjenta | 23 | $29,714 | $1,292 |
| Novolog Flexpen | 35 | $28,273 | $808 |
| Rayaldee | 16 | $26,172 | $1,636 |
| Eliquis | 28 | $25,508 | $911 |
| Lantus Solostar | 29 | $25,198 | $869 |
| Retacrit | 32 | $24,030 | $751 |
| Repatha | 25 | $18,775 | $751 |
| Dronabinol | 26 | $17,442 | $671 |
| Midodrine | 48 | $16,547 | $345 |
| Calcium Acetate | 50 | $15,395 | $308 |
| Repatha Sureclick | 13 | $15,360 | $1,182 |
| Clinisol | 71 | $14,281 | $201 |
| Bumetanide | 167 | $12,890 | $77 |
| Megestrol Acetate | 54 | $11,987 | $222 |
| Tresiba Flextouch U-100 | 13 | $11,559 | $889 |
| Comfort Ez Pen Needle | 45 | $11,230 | $250 |
| Sucralfate | 35 | $8,170 | $233 |
| Basaglar Kwikpen U-100 | 15 | $6,169 | $411 |
| Potassium Citrate Er | 32 | $6,144 | $192 |
| Minoxidil | 86 | $5,433 | $63 |
| Febuxostat | 13 | $5,159 | $397 |
| Atorvastatin | 339 | $5,131 | $15 |
| Nifedipine Er | 53 | $4,343 | $82 |
| Levothyroxine | 187 | $3,551 | $19 |
| Pantoprazole | 115 | $3,353 | $29 |
| Lisinopril | 256 | $3,170 | $12 |
| Hydralazine | 113 | $2,784 | $25 |
| Albuterol Sulfate Hfa | 51 | $2,538 | $50 |
| Valsartan | 23 | $2,509 | $109 |
| Allopurinol | 116 | $2,315 | $20 |
| Tamsulosin | 98 | $2,030 | $21 |
| Eszopiclone | 16 | $1,883 | $118 |
| Carvedilol | 116 | $1,789 | $15 |
| Celecoxib | 19 | $1,697 | $89 |
| Ezetimibe | 16 | $1,650 | $103 |
| Losartan | 95 | $1,605 | $17 |
| Gabapentin | 47 | $1,603 | $34 |
| Alprazolam | 256 | $1,577 | $6 |
| Oxybutynin Chloride Er | 13 | $1,398 | $108 |
| Gemfibrozil | 47 | $1,302 | $28 |
| Metoprolol | 143 | $1,302 | $9 |
| Potassium Chloride | 46 | $1,277 | $28 |
| Finasteride | 30 | $1,100 | $37 |
| Fludrocortisone Acetate | 12 | $1,080 | $90 |
| Metoprolol | 51 | $1,071 | $21 |
| Azelastine | 12 | $998 | $83 |
| Calcitriol | 29 | $967 | $33 |
| Hydrocodone-Acetaminophen | 101 | $908 | $9 |
| Amlodipine Besylate | 69 | $855 | $12 |
| Clonidine | 56 | $844 | $15 |
| Fenofibrate | 12 | $808 | $67 |
| Ventolin Hfa | 13 | $793 | $61 |
| Doxazosin Mesylate | 31 | $784 | $25 |
| Ondansetron Odt | 34 | $738 | $22 |
| Ondansetron | 49 | $694 | $14 |
| Isosorbide Mononitrate Er | 28 | $622 | $22 |
| Gentamicin Sulfate | 11 | $617 | $56 |
| Ropinirole | 12 | $610 | $51 |
| Olmesartan Medoxomil | 22 | $577 | $26 |
| Chlorthalidone | 19 | $573 | $30 |
| Labetalol | 11 | $572 | $52 |
| Fluticasone Propionate | 51 | $560 | $11 |
| Enalapril Maleate | 13 | $485 | $37 |
| Rosuvastatin | 23 | $477 | $21 |
| Constulose | 14 | $452 | $32 |
| Ciprofloxacin | 64 | $411 | $6 |
| Clopidogrel | 27 | $400 | $15 |
| Azithromycin | 34 | $396 | $12 |
| Metolazone | 25 | $396 | $16 |
| Zolpidem | 75 | $374 | $5 |
| Atenolol | 21 | $346 | $16 |
| Comfort Ez Insulin | 25 | $342 | $14 |
| Omeprazole | 24 | $313 | $13 |
| Famotidine | 16 | $293 | $18 |
| Vitamin D2 | 32 | $285 | $9 |
| Furosemide | 34 | $266 | $8 |
| Prednisone | 47 | $250 | $5 |
| Warfarin | 27 | $235 | $9 |
| Spironolactone | 29 | $205 | $7 |
| Benazepril | 11 | $205 | $19 |
| Sertraline | 42 | $200 | $5 |
| Hydromorphone | 22 | $190 | $9 |
| Hydrochlorothiazide | 30 | $189 | $6 |
| Amoxicillin-Clavulanate Potass | 24 | $184 | $8 |
| Simvastatin | 21 | $181 | $9 |
| Paroxetine | 11 | $175 | $16 |
| Oxycodone | 12 | $146 | $12 |
| Cephalexin | 15 | $131 | $9 |
| Terbinafine | 11 | $101 | $9 |
| Fluconazole | 12 | $85 | $7 |
| Tramadol | 13 | $21 | $2 |
2021: 89 drugs
| Velphoro | 69 | $274,666 | $3,981 |
| Sevelamer Carbonate | 139 | $106,807 | $768 |
| Prosol | 438 | $71,630 | $164 |
| Xifaxan | 18 | $57,784 | $3,210 |
| Januvia | 41 | $50,001 | $1,220 |
| Glyxambi | 25 | $41,231 | $1,649 |
| Novolog Flexpen | 32 | $39,863 | $1,246 |
| Cinacalcet | 102 | $38,010 | $373 |
| Eliquis | 51 | $37,669 | $739 |
| Procrit | 13 | $33,620 | $2,586 |
| Clinolipid | 119 | $32,866 | $276 |
| Lantus Solostar | 34 | $30,048 | $884 |
| Rayaldee | 11 | $26,699 | $2,427 |
| Retacrit | 42 | $24,822 | $591 |
| Tradjenta | 15 | $22,098 | $1,473 |
| Veltassa | 17 | $21,295 | $1,253 |
| Dronabinol | 33 | $15,236 | $462 |
| Midodrine | 67 | $14,714 | $220 |
| Bumetanide | 191 | $14,105 | $74 |
| Lokelma | 15 | $13,606 | $907 |
| Clinisol | 72 | $13,553 | $188 |
| Calcium Acetate | 59 | $12,630 | $214 |
| Comfort Ez Pen Needle | 42 | $12,172 | $290 |
| Basaglar Kwikpen U-100 | 16 | $7,116 | $445 |
| Levothyroxine | 194 | $4,370 | $23 |
| Potassium Citrate Er | 13 | $4,266 | $328 |
| Atorvastatin | 286 | $4,119 | $14 |
| Nifedipine Er | 45 | $4,005 | $89 |
| Minoxidil | 83 | $3,788 | $46 |
| Hydralazine | 130 | $3,681 | $28 |
| Lactulose | 52 | $3,597 | $69 |
| Albuterol Sulfate Hfa | 55 | $3,032 | $55 |
| Allopurinol | 132 | $2,476 | $19 |
| Ezetimibe | 20 | $2,330 | $116 |
| Megestrol Acetate | 38 | $1,981 | $52 |
| Fenofibrate | 29 | $1,920 | $66 |
| Gabapentin | 54 | $1,886 | $35 |
| Lisinopril | 178 | $1,879 | $11 |
| Carvedilol | 112 | $1,559 | $14 |
| Celecoxib | 21 | $1,548 | $74 |
| Gemfibrozil | 48 | $1,540 | $32 |
| Tamsulosin | 95 | $1,528 | $16 |
| Pantoprazole | 94 | $1,509 | $16 |
| Alprazolam | 193 | $1,470 | $8 |
| Sucralfate | 27 | $1,426 | $53 |
| Potassium Chloride | 27 | $1,326 | $49 |
| Ventolin Hfa | 18 | $1,272 | $71 |
| Clonidine | 54 | $1,198 | $22 |
| Olmesartan Medoxomil | 24 | $1,148 | $48 |
| Metoprolol | 110 | $1,016 | $9 |
| Constulose | 14 | $892 | $64 |
| Losartan | 62 | $855 | $14 |
| Doxazosin Mesylate | 30 | $828 | $28 |
| Calcitriol | 19 | $789 | $42 |
| Hydrocodone-Acetaminophen | 74 | $784 | $11 |
| Metoprolol | 42 | $735 | $17 |
| Fluticasone Propionate | 66 | $717 | $11 |
| Azithromycin | 41 | $705 | $17 |
| Amlodipine Besylate | 74 | $678 | $9 |
| Paricalcitol | 17 | $658 | $39 |
| Oxybutynin Chloride Er | 13 | $643 | $49 |
| Loperamide | 21 | $627 | $30 |
| Ciprofloxacin | 81 | $536 | $7 |
| Atenolol | 19 | $527 | $28 |
| Furosemide | 54 | $498 | $9 |
| Spironolactone | 59 | $484 | $8 |
| Lidocaine-Prilocaine | 14 | $479 | $34 |
| Finasteride | 17 | $449 | $26 |
| Diltiazem 24hr Er (Cd) | 16 | $446 | $28 |
| Zolpidem | 68 | $441 | $6 |
| Clopidogrel | 28 | $439 | $16 |
| Ondansetron Odt | 23 | $435 | $19 |
| Ondansetron | 34 | $413 | $12 |
| Isosorbide Mononitrate Er | 27 | $405 | $15 |
| Omeprazole | 27 | $370 | $14 |
| Amoxicillin-Clavulanate Potass | 25 | $354 | $14 |
| Rosuvastatin | 16 | $350 | $22 |
| Prednisone | 44 | $325 | $7 |
| Hydromorphone | 25 | $254 | $10 |
| Simvastatin | 26 | $252 | $10 |
| Warfarin | 33 | $248 | $8 |
| Cephalexin | 23 | $234 | $10 |
| Sertraline | 47 | $231 | $5 |
| Hydrochlorothiazide | 34 | $222 | $7 |
| Metronidazole | 18 | $183 | $10 |
| Vitamin D2 | 30 | $178 | $6 |
| Oxycodone | 15 | $156 | $10 |
| Metolazone | 21 | $147 | $7 |
| Comfort Ez Insulin | 11 | $106 | $10 |
2020: 96 drugs
| Velphoro | 69 | $196,338 | $2,845 |
| Prosol | 392 | $84,824 | $216 |
| Cinacalcet | 161 | $58,637 | $364 |
| Glyxambi | 35 | $55,419 | $1,583 |
| Procrit | 39 | $53,666 | $1,376 |
| Lantus Solostar | 61 | $48,572 | $796 |
| Retacrit | 84 | $47,231 | $562 |
| Sevelamer Carbonate | 90 | $40,419 | $449 |
| Tradjenta | 29 | $38,540 | $1,329 |
| Rayaldee | 13 | $38,009 | $2,924 |
| Januvia | 28 | $34,382 | $1,228 |
| Novolog Flexpen | 25 | $34,067 | $1,363 |
| Clinisol | 207 | $32,500 | $157 |
| Veltassa | 14 | $28,068 | $2,005 |
| Eliquis | 34 | $25,624 | $754 |
| Auryxia | 12 | $21,566 | $1,797 |
| Lokelma | 12 | $17,019 | $1,418 |
| Bumetanide | 195 | $14,707 | $75 |
| Epogen | 16 | $13,793 | $862 |
| Calcium Acetate | 64 | $12,188 | $190 |
| Clinolipid | 47 | $11,886 | $253 |
| Trulicity | 12 | $9,540 | $795 |
| Midodrine | 62 | $8,994 | $145 |
| Febuxostat | 23 | $6,954 | $302 |
| Basaglar Kwikpen U-100 | 18 | $6,645 | $369 |
| Nifedipine Er | 46 | $6,374 | $139 |
| Levothyroxine | 201 | $5,493 | $27 |
| Advair Diskus | 13 | $5,402 | $416 |
| Potassium Citrate Er | 12 | $5,082 | $423 |
| Hydralazine | 152 | $4,943 | $33 |
| Comfort Ez Pen Needle | 20 | $4,636 | $232 |
| Megestrol Acetate | 69 | $4,446 | $64 |
| Minoxidil | 90 | $4,437 | $49 |
| Intralipid | 27 | $4,388 | $163 |
| Atorvastatin | 267 | $3,832 | $14 |
| Albuterol Sulfate Hfa | 55 | $3,285 | $60 |
| Ventolin Hfa | 42 | $2,538 | $60 |
| Lactulose | 49 | $2,301 | $47 |
| Lisinopril | 194 | $2,195 | $11 |
| Allopurinol | 130 | $1,951 | $15 |
| Fenofibrate | 31 | $1,832 | $59 |
| Olmesartan Medoxomil | 24 | $1,549 | $65 |
| Celecoxib | 26 | $1,521 | $59 |
| Sucralfate | 35 | $1,508 | $43 |
| Pantoprazole | 108 | $1,377 | $13 |
| Gemfibrozil | 42 | $1,300 | $31 |
| Tamsulosin | 93 | $1,265 | $14 |
| Gabapentin | 55 | $1,250 | $23 |
| Alcohol Prep Pads | 14 | $1,143 | $82 |
| Alprazolam | 213 | $1,134 | $5 |
| Carvedilol | 109 | $1,127 | $10 |
| Potassium Chloride | 28 | $1,057 | $38 |
| Clonidine | 54 | $978 | $18 |
| Fluticasone Propionate | 57 | $871 | $15 |
| Metoprolol | 111 | $813 | $7 |
| Ultra-Fine Mini Pen Needle | 17 | $796 | $47 |
| Paricalcitol | 15 | $769 | $51 |
| Atenolol | 27 | $704 | $26 |
| Ondansetron Odt | 28 | $696 | $25 |
| Amlodipine Besylate | 85 | $669 | $8 |
| Doxazosin Mesylate | 20 | $646 | $32 |
| Furosemide | 75 | $646 | $9 |
| Constulose | 12 | $641 | $53 |
| Hydrocodone-Acetaminophen | 78 | $636 | $8 |
| Ropinirole | 15 | $617 | $41 |
| Ondansetron | 31 | $561 | $18 |
| Ezetimibe | 12 | $554 | $46 |
| Finasteride | 21 | $550 | $26 |
| Metoprolol | 19 | $545 | $29 |
| Clopidogrel | 33 | $506 | $15 |
| Omeprazole | 36 | $498 | $14 |
| Spironolactone | 74 | $496 | $7 |
| Irbesartan | 11 | $479 | $44 |
| Calcitriol | 14 | $469 | $33 |
| Diltiazem 24hr Er (Cd) | 15 | $443 | $30 |
| Losartan | 29 | $430 | $15 |
| Cephalexin | 36 | $408 | $11 |
| Azithromycin | 33 | $406 | $12 |
| Isosorbide Mononitrate Er | 25 | $402 | $16 |
| Levetiracetam | 11 | $347 | $32 |
| Zolpidem | 54 | $328 | $6 |
| Metolazone | 31 | $319 | $10 |
| Ciprofloxacin | 57 | $274 | $5 |
| Simvastatin | 30 | $272 | $9 |
| Famotidine | 14 | $259 | $19 |
| Prednisone | 54 | $250 | $5 |
| Sertraline | 40 | $249 | $6 |
| Warfarin | 30 | $239 | $8 |
| Oxycodone | 15 | $183 | $12 |
| Hydrochlorothiazide | 22 | $170 | $8 |
| Oxycodone-Acetaminophen | 12 | $150 | $12 |
| Hydromorphone | 26 | $144 | $6 |
| Glimepiride | 12 | $132 | $11 |
| Tramadol | 30 | $87 | $3 |
| Clonazepam | 14 | $74 | $5 |
| Levofloxacin | 14 | $39 | $3 |
2019: 84 drugs
| Velphoro | 40 | $102,113 | $2,553 |
| Prosol | 387 | $81,454 | $210 |
| Renvela | 24 | $66,370 | $2,765 |
| Procrit | 46 | $56,767 | $1,234 |
| Glyxambi | 34 | $48,063 | $1,414 |
| Lantus Solostar | 55 | $41,178 | $749 |
| Sevelamer Carbonate | 55 | $40,438 | $735 |
| Sensipar | 59 | $33,504 | $568 |
| Clinisol | 205 | $31,542 | $154 |
| Cinacalcet | 47 | $31,150 | $663 |
| Novolog Flexpen | 27 | $22,879 | $847 |
| Tradjenta | 20 | $22,087 | $1,104 |
| Intralipid | 121 | $18,338 | $152 |
| Januvia | 16 | $16,714 | $1,045 |
| Epogen | 26 | $15,684 | $603 |
| Veltassa | 12 | $15,386 | $1,282 |
| Eliquis | 14 | $14,607 | $1,043 |
| Levemir Flextouch | 18 | $11,907 | $662 |
| Bumetanide | 164 | $10,230 | $62 |
| Calcium Acetate | 74 | $8,475 | $115 |
| Retacrit | 14 | $6,495 | $464 |
| Midodrine | 57 | $6,357 | $112 |
| Basaglar Kwikpen U-100 | 14 | $4,882 | $349 |
| Nifedipine Er | 38 | $4,453 | $117 |
| Atorvastatin | 216 | $4,050 | $19 |
| Minoxidil | 90 | $3,941 | $44 |
| Levothyroxine | 154 | $3,884 | $25 |
| Ventolin Hfa | 59 | $3,386 | $57 |
| Hydralazine | 111 | $3,353 | $30 |
| Dextrose in Water | 167 | $2,842 | $17 |
| Clonidine | 14 | $2,799 | $200 |
| Felodipine Er | 32 | $2,296 | $72 |
| Tamsulosin | 80 | $2,060 | $26 |
| Lisinopril | 161 | $2,047 | $13 |
| Olmesartan Medoxomil | 22 | $1,877 | $85 |
| Allopurinol | 97 | $1,874 | $19 |
| Megestrol Acetate | 31 | $1,662 | $54 |
| Ondansetron Odt | 43 | $1,535 | $36 |
| Alprazolam | 205 | $1,452 | $7 |
| Carvedilol | 101 | $1,420 | $14 |
| Pantoprazole | 77 | $1,414 | $18 |
| Celecoxib | 23 | $1,131 | $49 |
| Fenofibrate | 21 | $1,106 | $53 |
| Gemfibrozil | 44 | $1,077 | $24 |
| Clonidine | 69 | $1,038 | $15 |
| Gabapentin | 36 | $1,016 | $28 |
| Metoprolol | 81 | $864 | $11 |
| Finasteride | 23 | $823 | $36 |
| Irbesartan | 18 | $811 | $45 |
| Azithromycin | 60 | $807 | $13 |
| Sucralfate | 24 | $798 | $33 |
| Fluticasone Propionate | 49 | $768 | $16 |
| Lactulose | 23 | $735 | $32 |
| Doxazosin Mesylate | 14 | $678 | $48 |
| Ultra-Fine Mini Pen Needle | 11 | $640 | $58 |
| Albuterol Sulfate Hfa | 14 | $636 | $45 |
| Amlodipine Besylate | 75 | $632 | $8 |
| Metoprolol | 20 | $602 | $30 |
| Potassium Chloride | 27 | $588 | $22 |
| Hydrocodone-Acetaminophen | 60 | $580 | $10 |
| Metolazone | 24 | $571 | $24 |
| Isosorbide Mononitrate Er | 22 | $562 | $26 |
| Zolpidem | 50 | $529 | $11 |
| Spironolactone | 49 | $526 | $11 |
| Furosemide | 50 | $491 | $10 |
| Ciprofloxacin | 60 | $472 | $8 |
| Clopidogrel | 19 | $399 | $21 |
| Atenolol | 15 | $363 | $24 |
| Cephalexin | 20 | $355 | $18 |
| Warfarin | 35 | $333 | $10 |
| Sertraline | 37 | $318 | $9 |
| Omeprazole | 24 | $307 | $13 |
| Prednisone | 68 | $298 | $4 |
| Simvastatin | 28 | $203 | $7 |
| Oxycodone | 15 | $198 | $13 |
| Constulose | 12 | $181 | $15 |
| Losartan | 11 | $164 | $15 |
| Hydrochlorothiazide | 20 | $156 | $8 |
| Montelukast | 14 | $155 | $11 |
| Hydromorphone | 30 | $151 | $5 |
| Lisinopril-Hydrochlorothiazide | 11 | $125 | $11 |
| Tramadol | 23 | $82 | $4 |
| Paroxetine | 12 | $73 | $6 |
| Hydrocortisone | 13 | $66 | $5 |
2018: 74 drugs
| Renvela | 70 | $185,323 | $2,647 |
| Prosol | 547 | $95,984 | $175 |
| Sensipar | 104 | $80,158 | $771 |
| Procrit | 70 | $68,445 | $978 |
| Sevelamer Carbonate | 46 | $49,744 | $1,081 |
| Tradjenta | 37 | $37,033 | $1,001 |
| Januvia | 35 | $35,246 | $1,007 |
| Epogen | 35 | $17,741 | $507 |
| Glyxambi | 14 | $16,924 | $1,209 |
| Clinisol | 87 | $12,856 | $148 |
| Calcium Acetate | 87 | $10,516 | $121 |
| Bumetanide | 135 | $9,327 | $69 |
| Levemir Flextouch | 16 | $8,777 | $549 |
| Lyrica | 13 | $7,100 | $546 |
| Novolog Flexpen | 11 | $6,421 | $584 |
| Midodrine | 59 | $5,313 | $90 |
| Intralipid | 32 | $5,253 | $164 |
| Atorvastatin | 211 | $3,720 | $18 |
| Celecoxib | 22 | $3,216 | $146 |
| Clonidine | 12 | $2,839 | $237 |
| Minoxidil | 112 | $2,747 | $25 |
| Hydralazine | 110 | $2,604 | $24 |
| Levothyroxine | 105 | $2,351 | $22 |
| Nifedipine Er | 29 | $2,147 | $74 |
| Valsartan | 28 | $2,028 | $72 |
| Fenofibrate | 32 | $1,789 | $56 |
| Lisinopril | 149 | $1,648 | $11 |
| Ventolin Hfa | 29 | $1,602 | $55 |
| Tamsulosin | 57 | $1,492 | $26 |
| Allopurinol | 65 | $1,432 | $22 |
| Metolazone | 20 | $1,097 | $55 |
| Alprazolam | 183 | $1,095 | $6 |
| Pantoprazole | 68 | $1,094 | $16 |
| Megestrol Acetate | 31 | $1,061 | $34 |
| Labetalol | 25 | $995 | $40 |
| Gemfibrozil | 50 | $873 | $17 |
| Metoprolol | 101 | $865 | $9 |
| Clonidine | 65 | $785 | $12 |
| Sucralfate | 29 | $733 | $25 |
| Warfarin | 35 | $714 | $20 |
| Gabapentin | 40 | $701 | $18 |
| Hydrocodone-Acetaminophen | 65 | $687 | $11 |
| Amlodipine Besylate | 82 | $622 | $8 |
| Fluticasone Propionate | 40 | $586 | $15 |
| Spironolactone | 42 | $578 | $14 |
| Carvedilol | 77 | $540 | $7 |
| Lactulose | 22 | $510 | $23 |
| Potassium Chloride | 15 | $509 | $34 |
| Finasteride | 19 | $489 | $26 |
| Metoprolol | 13 | $454 | $35 |
| Glimepiride | 19 | $449 | $24 |
| Olmesartan Medoxomil | 16 | $442 | $28 |
| Dextrose in Water | 138 | $429 | $3 |
| Ondansetron Odt | 37 | $415 | $11 |
| Enalapril Maleate | 14 | $368 | $26 |
| Azithromycin | 27 | $345 | $13 |
| Losartan | 37 | $316 | $9 |
| Zolpidem | 29 | $307 | $11 |
| Atenolol | 19 | $290 | $15 |
| Montelukast | 23 | $286 | $12 |
| Prednisone | 20 | $275 | $14 |
| Meclizine | 11 | $268 | $24 |
| Clopidogrel | 22 | $267 | $12 |
| Ciprofloxacin | 43 | $258 | $6 |
| Furosemide | 34 | $240 | $7 |
| Omeprazole | 25 | $236 | $9 |
| Simvastatin | 38 | $179 | $5 |
| Mirtazapine | 17 | $144 | $8 |
| Hydromorphone | 25 | $126 | $5 |
| Sertraline | 19 | $115 | $6 |
| Famotidine | 16 | $114 | $7 |
| Metronidazole | 11 | $103 | $9 |
| Hydrochlorothiazide | 24 | $84 | $4 |
| Tramadol | 15 | $24 | $2 |
2017: 79 drugs
| Sensipar | 257 | $404,200 | $1,573 |
| Renvela | 158 | $313,355 | $1,983 |
| Prosol | 499 | $113,833 | $228 |
| Januvia | 67 | $42,282 | $631 |
| Tradjenta | 39 | $27,886 | $715 |
| Epogen | 26 | $24,796 | $954 |
| Procrit | 15 | $20,714 | $1,381 |
| Fosrenol | 17 | $19,143 | $1,126 |
| Lantus Solostar | 23 | $14,610 | $635 |
| Calcium Acetate | 90 | $14,322 | $159 |
| Veltassa | 12 | $11,782 | $982 |
| Lantus | 15 | $11,589 | $773 |
| Novolog Flexpen | 12 | $8,934 | $744 |
| Bumetanide | 150 | $7,881 | $53 |
| Dexilant | 17 | $7,036 | $414 |
| Uloric | 11 | $5,679 | $516 |
| Dextrose in Water | 110 | $4,976 | $45 |
| Midodrine | 61 | $4,699 | $77 |
| Edarbi | 14 | $4,429 | $316 |
| Celecoxib | 33 | $3,838 | $116 |
| Valsartan | 54 | $3,022 | $56 |
| Minoxidil | 109 | $2,910 | $27 |
| Atorvastatin | 196 | $2,841 | $14 |
| Olmesartan Medoxomil | 14 | $2,675 | $191 |
| Clinisol | 18 | $2,609 | $145 |
| Hydralazine | 127 | $2,396 | $19 |
| Fenofibrate | 57 | $2,203 | $39 |
| Lisinopril | 235 | $2,038 | $9 |
| Allopurinol | 81 | $2,000 | $25 |
| Metolazone | 36 | $1,745 | $48 |
| Tamsulosin | 66 | $1,572 | $24 |
| Ventolin Hfa | 26 | $1,390 | $53 |
| Levothyroxine | 76 | $1,310 | $17 |
| Cholestyramine | 11 | $1,115 | $101 |
| Nifedipine Er | 20 | $870 | $43 |
| Enalapril Maleate | 15 | $801 | $53 |
| Pantoprazole | 97 | $790 | $8 |
| Alprazolam | 191 | $747 | $4 |
| Gabapentin | 69 | $734 | $11 |
| Labetalol | 23 | $727 | $32 |
| Amlodipine Besylate | 123 | $707 | $6 |
| Carvedilol | 89 | $698 | $8 |
| Sucralfate | 26 | $697 | $27 |
| Proair Hfa | 12 | $692 | $58 |
| Potassium Chloride | 18 | $671 | $37 |
| Metoprolol | 15 | $668 | $45 |
| Gemfibrozil | 47 | $591 | $13 |
| Metoprolol | 115 | $586 | $5 |
| Clonidine | 64 | $565 | $9 |
| Spironolactone | 49 | $561 | $11 |
| Duloxetine | 21 | $525 | $25 |
| Azithromycin | 44 | $483 | $11 |
| Glimepiride | 21 | $445 | $21 |
| Hydrocodone-Acetaminophen | 71 | $425 | $6 |
| Cephalexin | 31 | $413 | $13 |
| Losartan | 48 | $373 | $8 |
| Clopidogrel | 28 | $343 | $12 |
| Ondansetron Odt | 28 | $329 | $12 |
| Fluticasone Propionate | 28 | $309 | $11 |
| Zolpidem | 40 | $295 | $7 |
| Prednisone | 41 | $288 | $7 |
| Finasteride | 16 | $280 | $18 |
| Sertraline | 45 | $260 | $6 |
| Omeprazole | 36 | $256 | $7 |
| Simvastatin | 39 | $256 | $7 |
| Furosemide | 50 | $251 | $5 |
| Valsartan-Hydrochlorothiazide | 11 | $245 | $22 |
| Promethazine | 15 | $242 | $16 |
| Ciprofloxacin | 47 | $225 | $5 |
| Mirtazapine | 19 | $207 | $11 |
| Warfarin | 15 | $202 | $13 |
| Montelukast | 20 | $195 | $10 |
| Atenolol | 13 | $175 | $13 |
| Lactulose | 17 | $171 | $10 |
| Pravastatin | 12 | $153 | $13 |
| Glipizide | 26 | $127 | $5 |
| Levofloxacin | 13 | $122 | $9 |
| Tramadol | 23 | $62 | $3 |
| Hydrochlorothiazide | 19 | $50 | $3 |
2016: 76 drugs
| Sensipar | 286 | $274,231 | $959 |
| Renvela | 176 | $252,585 | $1,435 |
| Prosol | 193 | $35,836 | $186 |
| Januvia | 60 | $35,301 | $588 |
| Procrit | 14 | $21,554 | $1,540 |
| Calcium Acetate | 111 | $17,048 | $154 |
| Lantus Solostar | 22 | $15,737 | $715 |
| Lantus | 25 | $9,728 | $389 |
| Midodrine | 56 | $8,630 | $154 |
| Lialda | 12 | $6,590 | $549 |
| Dexilant | 23 | $6,053 | $263 |
| Bumetanide | 150 | $5,540 | $37 |
| Uloric | 16 | $5,076 | $317 |
| Tradjenta | 12 | $4,955 | $413 |
| Celecoxib | 29 | $4,682 | $161 |
| Hydralazine | 189 | $3,607 | $19 |
| Benicar | 11 | $3,230 | $294 |
| Atorvastatin | 167 | $2,455 | $15 |
| Metolazone | 24 | $2,421 | $101 |
| Paricalcitol | 26 | $2,007 | $77 |
| Clinisol | 18 | $1,676 | $93 |
| Lisinopril | 221 | $1,616 | $7 |
| Proair Hfa | 23 | $1,531 | $67 |
| Lidocaine-Prilocaine | 24 | $1,434 | $60 |
| Duloxetine | 40 | $1,388 | $35 |
| Hydrocodone-Acetaminophen | 106 | $1,381 | $13 |
| Allopurinol | 78 | $1,323 | $17 |
| Cholestyramine | 11 | $1,289 | $117 |
| Valsartan | 32 | $1,252 | $39 |
| Levothyroxine | 79 | $1,192 | $15 |
| Tamsulosin | 35 | $1,150 | $33 |
| Pantoprazole | 131 | $1,113 | $8 |
| Nifedical Xl | 18 | $958 | $53 |
| Amlodipine Besylate | 148 | $809 | $5 |
| Alprazolam | 173 | $792 | $5 |
| Clonidine | 85 | $773 | $9 |
| Fenofibrate | 29 | $763 | $26 |
| Gabapentin | 66 | $754 | $11 |
| Gemfibrozil | 57 | $680 | $12 |
| Dextrose in Water | 14 | $667 | $48 |
| Pravastatin | 19 | $657 | $35 |
| Minoxidil | 37 | $654 | $18 |
| Sodium Chloride | 46 | $599 | $13 |
| Carvedilol | 91 | $597 | $7 |
| Metoprolol | 107 | $587 | $5 |
| Enalapril Maleate | 18 | $567 | $32 |
| Azithromycin | 39 | $563 | $14 |
| Potassium Chloride | 22 | $556 | $25 |
| Metoprolol | 23 | $533 | $23 |
| Nifedipine Er | 19 | $504 | $27 |
| Clopidogrel | 36 | $416 | $12 |
| Zolpidem | 46 | $413 | $9 |
| Losartan | 39 | $373 | $10 |
| Furosemide | 65 | $363 | $6 |
| Ciprofloxacin | 54 | $343 | $6 |
| Ondansetron Odt | 17 | $325 | $19 |
| Diltiazem 24hr Cd | 12 | $274 | $23 |
| Lactulose | 19 | $250 | $13 |
| Sertraline | 34 | $232 | $7 |
| Glimepiride | 24 | $211 | $9 |
| Meclizine | 11 | $204 | $19 |
| Omeprazole | 30 | $201 | $7 |
| Montelukast | 13 | $196 | $15 |
| Glipizide | 33 | $192 | $6 |
| Prednisone | 22 | $183 | $8 |
| Generlac | 12 | $175 | $15 |
| Cephalexin | 24 | $175 | $7 |
| Levofloxacin | 16 | $151 | $9 |
| Triamcinolone Acetonide | 12 | $148 | $12 |
| Divalproex | 13 | $124 | $10 |
| Simvastatin | 17 | $109 | $6 |
| Atenolol | 11 | $93 | $8 |
| Hydromorphone | 15 | $91 | $6 |
| Hydrochlorothiazide | 23 | $80 | $3 |
| Warfarin | 14 | $73 | $5 |
| Hydrocortisone | 11 | $71 | $6 |
2015: 78 drugs
| Renvela | 131 | $140,743 | $1,074 |
| Sensipar | 146 | $126,481 | $866 |
| Prosol | 115 | $23,120 | $201 |
| Januvia | 41 | $20,512 | $500 |
| Calcium Acetate | 102 | $13,521 | $133 |
| Fosrenol | 15 | $12,723 | $848 |
| Epogen | 11 | $9,128 | $830 |
| Novolog | 21 | $7,689 | $366 |
| Auryxia | 15 | $6,820 | $455 |
| Lantus | 23 | $6,792 | $295 |
| Doxercalciferol | 19 | $6,191 | $326 |
| Midodrine | 39 | $5,925 | $152 |
| Nexium | 16 | $4,981 | $311 |
| Lialda | 11 | $4,847 | $441 |
| Zetia | 16 | $4,707 | $294 |
| Clinisol | 50 | $4,650 | $93 |
| Dexilant | 20 | $4,378 | $219 |
| Lantus Solostar | 11 | $4,124 | $375 |
| Uloric | 16 | $4,094 | $256 |
| Diovan | 13 | $3,556 | $274 |
| Tekturna | 11 | $2,903 | $264 |
| Bumetanide | 50 | $2,629 | $53 |
| Fenofibrate | 22 | $2,333 | $106 |
| Paricalcitol | 28 | $2,175 | $78 |
| Celecoxib | 20 | $2,149 | $107 |
| Benicar | 11 | $1,930 | $175 |
| Atorvastatin | 131 | $1,593 | $12 |
| Proair Hfa | 29 | $1,484 | $51 |
| Hydralazine | 79 | $1,373 | $17 |
| Nifedipine Er | 19 | $1,238 | $65 |
| Metolazone | 19 | $995 | $52 |
| Dextrose in Water | 21 | $991 | $47 |
| Amlodipine Besylate | 173 | $987 | $6 |
| Lisinopril | 158 | $981 | $6 |
| Diltiazem 24hr Cd | 12 | $965 | $80 |
| Metoprolol | 42 | $951 | $23 |
| Levothyroxine | 72 | $936 | $13 |
| Duloxetine | 21 | $935 | $45 |
| Pantoprazole | 105 | $905 | $9 |
| Enalapril Maleate | 30 | $903 | $30 |
| Generlac | 16 | $832 | $52 |
| Gemfibrozil | 64 | $702 | $11 |
| Hydrocodone-Acetaminophen | 63 | $653 | $10 |
| Afeditab Cr | 13 | $635 | $49 |
| Valsartan | 13 | $628 | $48 |
| Alprazolam | 125 | $616 | $5 |
| Allopurinol | 61 | $594 | $10 |
| Sodium Chloride | 36 | $563 | $16 |
| Tamsulosin | 22 | $497 | $23 |
| Azithromycin | 33 | $487 | $15 |
| Doxazosin Mesylate | 13 | $484 | $37 |
| Pravastatin | 28 | $484 | $17 |
| Meclizine | 23 | $433 | $19 |
| Ondansetron Odt | 29 | $385 | $13 |
| Furosemide | 81 | $363 | $4 |
| Carvedilol | 72 | $359 | $5 |
| Montelukast | 22 | $332 | $15 |
| Lactulose | 20 | $330 | $16 |
| Gabapentin | 51 | $320 | $6 |
| Potassium Chloride | 24 | $315 | $13 |
| Clopidogrel | 54 | $284 | $5 |
| Metoprolol | 56 | $259 | $5 |
| Cephalexin | 20 | $251 | $13 |
| Omeprazole | 37 | $250 | $7 |
| Glipizide | 36 | $236 | $7 |
| Zolpidem | 19 | $216 | $11 |
| Ciprofloxacin | 38 | $191 | $5 |
| Clonidine | 34 | $163 | $5 |
| Spironolactone | 16 | $160 | $10 |
| Minoxidil | 11 | $131 | $12 |
| Atenolol | 26 | $119 | $5 |
| Glimepiride | 17 | $117 | $7 |
| Prednisone | 19 | $109 | $6 |
| Lovastatin | 18 | $95 | $5 |
| Benazepril | 11 | $77 | $7 |
| Metformin | 13 | $72 | $6 |
| Sertraline | 18 | $69 | $4 |
| Ibuprofen | 13 | $51 | $4 |
2014: 60 drugs
| Sensipar | 90 | $75,970 | $844 |
| Renvela | 45 | $44,367 | $986 |
| Calcium Acetate | 96 | $13,885 | $145 |
| Lantus | 29 | $11,359 | $392 |
| Fosrenol | 14 | $11,077 | $791 |
| Prosol | 37 | $9,146 | $247 |
| Januvia | 22 | $9,097 | $413 |
| Diovan | 31 | $8,017 | $259 |
| Doxercalciferol | 17 | $7,311 | $430 |
| Novolog | 26 | $7,238 | $278 |
| Celebrex | 25 | $5,307 | $212 |
| Namenda | 12 | $3,709 | $309 |
| Dexilant | 15 | $2,877 | $192 |
| Zetia | 15 | $2,687 | $179 |
| Fenofibrate | 17 | $2,666 | $157 |
| Paricalcitol | 25 | $1,842 | $74 |
| Lisinopril | 234 | $1,798 | $8 |
| Hydralazine | 82 | $1,550 | $19 |
| Proair Hfa | 26 | $1,261 | $49 |
| Atorvastatin | 98 | $1,207 | $12 |
| Bumetanide | 39 | $1,149 | $29 |
| Midodrine | 14 | $1,126 | $80 |
| Minoxidil | 31 | $764 | $25 |
| Dextrose in Water | 17 | $723 | $43 |
| Gemfibrozil | 41 | $689 | $17 |
| Ondansetron Odt | 28 | $655 | $23 |
| Amlodipine Besylate | 95 | $647 | $7 |
| Potassium Chloride | 44 | $596 | $14 |
| Ondansetron | 11 | $574 | $52 |
| Pantoprazole | 61 | $570 | $9 |
| Metolazone | 21 | $519 | $25 |
| Azithromycin | 22 | $459 | $21 |
| Carvedilol | 63 | $438 | $7 |
| Hydrocodone-Acetaminophen | 45 | $436 | $10 |
| Levothyroxine | 29 | $430 | $15 |
| Metoprolol | 73 | $418 | $6 |
| Pravastatin | 11 | $391 | $36 |
| Enalapril Maleate | 29 | $371 | $13 |
| Lactulose | 21 | $360 | $17 |
| Gabapentin | 51 | $351 | $7 |
| Allopurinol | 67 | $342 | $5 |
| Furosemide | 83 | $324 | $4 |
| Clopidogrel | 38 | $300 | $8 |
| Lovastatin | 21 | $266 | $13 |
| Tamsulosin | 13 | $243 | $19 |
| Warfarin | 25 | $239 | $10 |
| Montelukast | 23 | $202 | $9 |
| Levofloxacin | 16 | $195 | $12 |
| Clonidine | 24 | $193 | $8 |
| Alprazolam | 45 | $185 | $4 |
| Omeprazole | 22 | $183 | $8 |
| Prednisone | 19 | $167 | $9 |
| Losartan | 19 | $166 | $9 |
| Ciprofloxacin | 26 | $145 | $6 |
| Simvastatin | 19 | $143 | $8 |
| Spironolactone | 12 | $128 | $11 |
| Sertraline | 19 | $101 | $5 |
| Hydromorphone | 16 | $94 | $6 |
| Atenolol | 14 | $72 | $5 |
| Glipizide | 23 | $71 | $3 |
2013: 40 drugs
| Sensipar | 83 | $51,472 | $620 |
| Renvela | 55 | $40,218 | $731 |
| Fosrenol | 27 | $22,652 | $839 |
| Hectorol | 27 | $9,619 | $356 |
| Januvia | 20 | $6,800 | $340 |
| Diovan | 26 | $6,637 | $255 |
| Calcium Acetate | 44 | $5,594 | $127 |
| Zemplar | 44 | $5,201 | $118 |
| Uloric | 13 | $3,425 | $263 |
| Advair Diskus | 11 | $2,901 | $264 |
| Celebrex | 15 | $2,715 | $181 |
| Lisinopril | 209 | $2,145 | $10 |
| Atorvastatin | 81 | $1,883 | $23 |
| Gemfibrozil | 52 | $1,089 | $21 |
| Ropinirole | 12 | $983 | $82 |
| Hydralazine | 46 | $847 | $18 |
| Proair Hfa | 15 | $697 | $46 |
| Azithromycin | 36 | $607 | $17 |
| Bd Ultra-Fine Pen Needle | 13 | $430 | $33 |
| Furosemide | 95 | $402 | $4 |
| Carvedilol | 37 | $328 | $9 |
| Clonidine | 34 | $327 | $10 |
| Losartan | 24 | $318 | $13 |
| Potassium Chloride | 23 | $295 | $13 |
| Minoxidil | 11 | $288 | $26 |
| Enalapril Maleate | 27 | $254 | $9 |
| Amlodipine Besylate | 31 | $234 | $8 |
| Pantoprazole | 18 | $225 | $12 |
| Tamsulosin | 17 | $217 | $13 |
| Metoprolol | 30 | $200 | $7 |
| Hydrocodone-Acetaminophen | 33 | $198 | $6 |
| Gabapentin | 25 | $181 | $7 |
| Ciprofloxacin | 32 | $168 | $5 |
| Sertraline | 12 | $126 | $11 |
| Omeprazole | 12 | $125 | $10 |
| Simvastatin | 15 | $116 | $8 |
| Zolpidem | 17 | $91 | $5 |
| Alprazolam | 16 | $78 | $5 |
| Famotidine | 12 | $70 | $6 |
| Benazepril | 15 | $68 | $5 |
Money from drug and device companies
$1,518 in 2025
| 2025 | 18 | 88 | None | $1,518 |
| 2024 | 14 | 69 | None | $1,144 |
| 2023 | 18 | 86 | None | $1,515 |
| 2022 | 17 | 90 | None | $1,470 |
| 2021 | 16 | 92 | None | $1,503 |
| 2020 | 8 | 34 | None | $574 |
| 2019 | 10 | 48 | None | $914 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ardelyx | Ibsrela | $258 | 18 payments
|
| Amgen | Otezla | $217 | 20 payments
|
| Mallinckrodt Hospital Products | Acthar | $166 | 7 payments
|
| Fresenius USA Marketing | Velphoro | $152 | 10 payments
|
| Novo Nordisk | Ozempic | $120 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $89 | 4 payments
|
See all 88 published payments
| Ardelyx | Meals · 2025-12-12 | Ibsrela | $5 |
| Ardelyx | Meals · 2025-12-12 | Ibsrela | $23 |
| Fresenius USA Marketing | Meals · 2025-12-11 | Velphoro | $20 |
| ANI Pharmaceuticals | Meals · 2025-12-05 | Purified Cortrophin Gel | $29 |
| Amgen | Meals · 2025-12-01 | Tavneos | $7 |
| Phathom Pharmaceuticals | Meals · 2025-11-26 | Voquezna | $3 |
| Phathom Pharmaceuticals | Meals · 2025-11-26 | Voquezna | $7 |
| Ardelyx | Meals · 2025-11-24 | Ibsrela | $9 |
| Travere Therapeutics | Meals · 2025-11-20 | None | $34 |
| ANI Pharmaceuticals | Meals · 2025-11-14 | Purified Cortrophin Gel | $28 |
| Novartis Pharmaceuticals | Meals · 2025-11-13 | Fabhalta | $27 |
| Lilly USA | Meals · 2025-11-03 | Jardiance | $26 |
| Fresenius USA Marketing | Meals · 2025-10-31 | Velphoro | $20 |
| Ardelyx | Meals · 2025-10-27 | Ibsrela | $8 |
| Phathom Pharmaceuticals | Meals · 2025-10-23 | Voquezna | $7 |
| Akebia Therapeutics | Meals · 2025-10-23 | Vafseo | $26 |
| Ardelyx | Meals · 2025-10-17 | Ibsrela | $24 |
| Fresenius USA Marketing | Meals · 2025-10-14 | Velphoro | $8 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-26 | Kerendia | $20 |
| Travere Therapeutics | Meals · 2025-09-24 | None | $9 |
| Novo Nordisk | Meals · 2025-09-19 | None | $19 |
| Mallinckrodt Hospital Products | Meals · 2025-09-18 | Acthar | $23 |
| Ardelyx | Meals · 2025-09-12 | Ibsrela | $19 |
| Fresenius USA Marketing | Meals · 2025-09-11 | Velphoro | $1 |
| Fresenius USA Marketing | Meals · 2025-09-11 | Velphoro | $20 |
| Amgen | Meals · 2025-09-03 | Tavneos | $15 |
| Amgen | Meals · 2025-08-26 | Tavneos | $7 |
| Calliditas Therapeutics US | Meals · 2025-08-22 | Tarpeyo | $35 |
| Ardelyx | Meals · 2025-08-21 | Ibsrela | $11 |
| Mallinckrodt Hospital Products | Meals · 2025-08-14 | Acthar | $24 |
| Ardelyx | Meals · 2025-08-01 | Ibsrela | $24 |
| Mallinckrodt Hospital Products | Meals · 2025-07-24 | Acthar | $23 |
| Ardelyx | Meals · 2025-07-14 | Ibsrela | $6 |
| Fresenius USA Marketing | Meals · 2025-07-03 | Velphoro | $21 |
| Novo Nordisk | Meals · 2025-06-27 | None | $18 |
| Ardelyx | Meals · 2025-06-25 | Ibsrela | $8 |
| Lilly USA | Meals · 2025-06-20 | Mounjaro | $18 |
| Mallinckrodt Hospital Products | Meals · 2025-06-13 | Acthar | $22 |
| Akebia Therapeutics | Meals · 2025-06-12 | Vafseo | $28 |
| Amgen | Meals · 2025-06-06 | Tavneos | $24 |
| Amgen | Meals · 2025-06-02 | Otezla | $8 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-23 | Kerendia | $25 |
| Ardelyx | Meals · 2025-05-23 | Ibsrela | $29 |
| Fresenius USA Marketing | Meals · 2025-05-22 | Velphoro | $19 |
| Amgen | Meals · 2025-05-21 | Otezla | $6 |
| Vifor Pharma | Meals · 2025-05-15 | Veltassa | $18 |
| Mallinckrodt Hospital Products | Meals · 2025-05-08 | Acthar | $23 |
| Amgen | Meals · 2025-05-07 | Otezla | $7 |
| CorMedix | Meals · 2025-05-02 | Defencath | $18 |
| Amgen | Meals · 2025-04-30 | Repatha | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-26 | Kerendia | $25 |
| Amgen | Meals · 2025-04-23 | Otezla | $9 |
| Ardelyx | Meals · 2025-04-11 | Ibsrela | $6 |
| Ardelyx | Meals · 2025-04-11 | Ibsrela | $3 |
| Mallinckrodt Hospital Products | Meals · 2025-04-10 | Acthar | $31 |
| Amgen | Meals · 2025-04-09 | Otezla | $7 |
| Otsuka America Pharmaceutical | Meals · 2025-04-09 | Jynarque | $21 |
| Akebia Therapeutics | Meals · 2025-04-04 | Vafseo | $28 |
| Calliditas Therapeutics US | Meals · 2025-03-29 | Tarpeyo | $25 |
| Ardelyx | Meals · 2025-03-27 | Ibsrela | $21 |
| Amgen | Meals · 2025-03-26 | Repatha | $8 |
| Mallinckrodt Hospital Products | Meals · 2025-03-21 | Acthar | $20 |
| Fresenius USA Marketing | Meals · 2025-03-20 | Velphoro | $16 |
| Novo Nordisk | Meals · 2025-03-15 | None | $19 |
| Amgen | Meals · 2025-03-13 | Otezla | $20 |
| Ardelyx | Meals · 2025-03-10 | Ibsrela | $7 |
| Amgen | Meals · 2025-03-05 | Otezla | $10 |
| Amgen | Meals · 2025-02-25 | Repatha | $7 |
| Novo Nordisk | Education · 2025-02-21 | Ozempic | $32 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-21 | Kerendia | $19 |
| Amgen | Meals · 2025-02-21 | Otezla | $7 |
| Fresenius USA Marketing | Meals · 2025-02-21 | Velphoro | $7 |
| Ardelyx | Meals · 2025-02-14 | Ibsrela | $26 |
| Otsuka America Pharmaceutical | Meals · 2025-02-13 | Jynarque | $24 |
| Amgen | Meals · 2025-02-12 | Otezla | $8 |
| Kyowa Kirin | Meals · 2025-02-06 | Crysvita | $30 |
| Amgen | Meals · 2025-02-06 | Otezla | $10 |
| Novo Nordisk | Education · 2025-02-05 | Ozempic | $32 |
| Amgen | Meals · 2025-01-31 | Tavneos | $24 |
| Ardelyx | Meals · 2025-01-31 | Ibsrela | $6 |
| Lilly USA | Meals · 2025-01-30 | Mounjaro | $20 |
| Amgen | Meals · 2025-01-30 | Otezla | $12 |
| Fresenius USA Marketing | Meals · 2025-01-23 | Velphoro | $21 |
| Abbott Laboratories | Meals · 2025-01-21 | Freestyle Libre 3 | $22 |
| Ardelyx | Meals · 2025-01-18 | Ibsrela | $23 |
| Novartis Pharmaceuticals | Meals · 2025-01-09 | None | $24 |
| Phathom Pharmaceuticals | Meals · 2025-01-08 | Voquezna | $9 |
| Amgen | Meals · 2025-01-07 | Otezla | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,144
| Amgen | Otezla | $273 | 20 payments
|
| Ardelyx | Ibsrela | $255 | 11 payments
|
| Calliditas Therapeutics US | Tarpeyo | $172 | 17 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $147 | 7 payments
|
| Otsuka America Pharmaceutical | Jynarque | $67 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $36 | 2 payments
|
| OPKO Pharmaceuticals | Rayaldee | $32 | 2 payments
|
| Kyowa Kirin | Crysvita | $28 | 1 payment
|
| Travere Therapeutics | None | $27 | 1 payment
|
| Novartis Pharmaceuticals | None | $26 | 1 payment
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $25 | 1 payment
|
| Novo Nordisk | None | $21 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2023: $1,515
| Amgen | Repatha | $268 | 20 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $204 | 7 payments
|
| Calliditas Therapeutics US | Tarpeyo | $163 | 8 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $152 | 5 payments
|
| Travere Therapeutics | None | $134 | 7 payments
|
| Vifor Pharma | Veltassa | $108 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $88 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $83 | 5 payments
|
| Otsuka America Pharmaceutical | Jynarque | $70 | 4 payments
|
| GlaxoSmithKline | Benlysta | $47 | 2 payments
|
| Lilly USA | Mounjaro | $36 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $33 | 1 payment
|
| Ardelyx | Ibsrela | $29 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $27 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $19 | 1 payment
|
| Novo Nordisk | None | $13 | 1 payment
|
2022: $1,470
| Amgen | Parsabiv | $199 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $180 | 9 payments
|
| Fresenius USA Marketing | Velphoro | $172 | 13 payments
|
| Horizon Therapeutics plc | Krystexxa | $164 | 8 payments
|
| Daiichi Sankyo | Injectafer | $136 | 14 payments
|
| GlaxoSmithKline | Benlysta | $124 | 6 payments
|
| Mallinckrodt Hospital Products | Acthar | $102 | 4 payments
|
| Exeltis USA | Purified Cortrophin Gel | $71 | 3 payments
|
| Otsuka America Pharmaceutical | Jynarque | $65 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $59 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $55 | 3 payments
|
| Akebia Therapeutics | Auryxia | $46 | 3 payments
|
| Vifor Pharma | None | $29 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $19 | 1 payment
|
| Novo Nordisk | None | $19 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $16 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
2021: $1,503
| Mallinckrodt Hospital Products | Acthar | $258 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $202 | 11 payments
|
| Horizon Therapeutics plc | Krystexxa | $167 | 11 payments
|
| Daiichi Sankyo | Injectafer | $150 | 12 payments
|
| Amgen | Parsabiv | $133 | 6 payments
|
| GlaxoSmithKline | Benlysta | $129 | 6 payments
|
| Fresenius USA Marketing | Velphoro | $123 | 10 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $68 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $55 | 3 payments
|
| Novo Nordisk | Rybelsus | $54 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $33 | 1 payment
|
| Akebia Therapeutics | Auryxia | $31 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $31 | 2 payments
|
| Insulet | Omnipod | $26 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $22 | 1 payment
|
| Vifor Pharma | Veltassa | $20 | 1 payment
|
2020: $574
| Fresenius USA Marketing | Velphoro | $139 | 11 payments
|
| Daiichi Sankyo | Injectafer | $121 | 7 payments
|
| Amgen | Parsabiv | $107 | 5 payments
|
| Otsuka America Pharmaceutical | Jynarque | $77 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $56 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $40 | 2 payments
|
| Akebia Therapeutics | Auryxia | $21 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $14 | 1 payment
|
2019: $914
| Amgen | Parsabiv | $259 | 7 payments
|
| Fresenius USA Marketing | Velphoro | $183 | 17 payments
|
| Otsuka America Pharmaceutical | Jynarque | $127 | 8 payments
|
| Akebia Therapeutics | Auryxia | $89 | 4 payments
|
| Daiichi Sankyo | Injectafer | $84 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $77 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $40 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $20 | 1 payment
|
| Relypsa | Veltassa | $19 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $16 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 642 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 92%That's most of the people this applied to. | 994 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 76%That's most of the people this applied to. | 637 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 45%That's less than half. Better on this measure. | 370 |
| Medications listed in the chartVisits where the current medication list was documented | 99%That's most of the people this applied to. | 7,517 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 721 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1467618363
- Licence
- CA A91481, WV 23178California A91481: Current · expires 2027-06-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- WV 3810012902
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 1700 S Court St, Suite D, Visalia, CA, 93277
- NPI first listed
- 2008-07-31
- NPI last updated
- 2017-03-17
This is when the NPI record was last certified, not a medical board exam.